N-Acetyl Semax Amidate (Nasal Spray) Protocol
A stabilized, longer-acting modification of Semax — the same ACTH(4-7)-Pro-Gly-Pro heptapeptide with its ends capped (N-acetyl, C-amide) to resist enzyme breakdown. Used intranasally as a nootropic. Its own controlled data are minimal; the evidence base is the Semax literature. Semax is registered only in Russia; neither is FDA-approved.
A stabilized modification of Semax (ACTH(4-7)-Pro-Gly-Pro): the same heptapeptide with an N-terminal acetyl group and a C-terminal amide added to resist enzymatic breakdown, making it longer-acting and more potent by weight. Used intranasally as a nootropic. It is a variant of the already-covered Semax, not a distinct drug.
Intranasal only: a 0.1% or 1% spray/solution, a few drops per nostril once or twice daily. Because the end-capping increases potency, users take less than plain Semax. No reconstitution, no injection. There is no validated amidate-specific dose; clinical Semax was dosed in course-based intranasal regimens.
The efficacy evidence is the Semax literature: neuroprotection in cerebral-ischemia models, up-regulation of BDNF and other neurotrophins, and antidepressant-like and pro-recovery effects, plus Russian clinical use in ischemic stroke. NA-Semax amidate itself has minimal dedicated controlled human data and leans on that base-Semax evidence. Semax is registered only in Russia; neither Semax nor the amidate is FDA-approved.
Quickstart Highlights
N-Acetyl Semax Amidate (often shortened to NA-Semax amidate or NASemax) is a stabilized modification of Semax. Semax is the synthetic heptapeptide ACTH(4-7)-Pro-Gly-Pro (Met-Glu-His-Phe-Pro-Gly-Pro), a noncorticotropic fragment analog of ACTH developed in Russia and used intranasally as a nootropic and neuroprotective agent[1][2]. The amidate version simply caps both ends of the peptide — an acetyl group on the N-terminus and an amide on the C-terminus.
Those two caps are the whole point: they make the peptide resist the enzymes that quickly chew up ordinary Semax, so NA-Semax amidate is marketed as longer-acting and more potent by weight. The honest catch is that almost all of the actual research is on base Semax, not the amidate[1][2][3][4]. NA-Semax amidate’s own controlled human data are minimal, Semax itself is registered only in Russia (not the amidate), and neither is FDA-approved. This is an educational reference, not medical advice.
Supplies Needed
NA-Semax amidate is used as a finished intranasal solution, so there is no reconstitution kit and no needle. What matters is a stable, correctly concentrated, well-preserved product and clean intranasal delivery; the peptide is the active, and knowing the exact concentration is what keeps dosing sane.
Protocol Overview
NA-Semax amidate is a stabilized analog of Semax, the noncorticotropic ACTH(4-7)-Pro-Gly-Pro heptapeptide developed in Russia and used intranasally for cognition, neuroprotection and recovery[1][2]. Capping the peptide’s ends (N-acetyl, C-amide) slows the enzymes that degrade it, giving a longer-acting, more potent version favoured by experienced nootropic users.
The overview’s honest core is the evidence relationship. The research base is Semax: neuroprotection in ischemia models, up-regulation of BDNF and neurotrophins, antidepressant-like and pro-recovery effects, and Russian clinical use in stroke[1][2][3][4]. NA-Semax amidate has minimal dedicated controlled human data and leans on that literature, so it is best understood as a more stable delivery of the same pharmacology — not a separately proven drug. Semax is registered only in Russia; neither is FDA-approved.
Dosing Protocol
Because NA-Semax amidate is intranasal, the “protocol” below is solution strength and application, not a reconstitution ladder. These figures are nootropic-market convention (with the base-Semax clinical regimen shown for context), not a validated amidate-specific dose.
| Parameter | Typical | Notes |
|---|---|---|
| Solution | 0.1% or 1% intranasal | Know the exact concentration |
| Frequency | A few drops/nostril, 1–2× daily | More potent → use less |
| Route | Intranasal (spray/drops) | No injection, no reconstitution |
| Base-Semax clinical dose[3] | ~6000 mcg/day × 10-day course | Semax in stroke, not the amidate |
Why N-Acetyl Semax Amidate draws research interest
These are the directions researchers and the peptide community most often explore N-Acetyl Semax Amidate for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Focus & cognition
The main draw: a stabilized Semax variant used as a nootropic. The clinical science belongs to plain Semax, not the amidate.
Stroke & neuroprotection
Semax is a registered intranasal drug in Russia for stroke and cognitive indications; the amidate variant is not a registered medicine.
BDNF & neurotrophins
Explored for raising BDNF in Russian-language research; that work is on Semax itself, and largely open-label.
More potent means less
The end caps slow degradation, so the practical amount is lower than plain Semax — a reason for restraint, not enthusiasm.
Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
An intranasal spray or drops, typically a 0.1% or 1% solution. No vial to reconstitute and no needle — it is delivered into the nose.
The N-acetyl and C-amide caps make the peptide resist exopeptidase breakdown, so it is longer-acting and more potent by weight than ordinary Semax[1].
A few drops per nostril once or twice daily; because it is more potent, users take less than plain Semax. Clinical Semax dosing is course-based (e.g. 10-day courses)[3].
Variant of Semax; leans on Semax data. The amidate’s own controlled trials are minimal; Semax is registered only in Russia. Neither is FDA-approved.
Dosing & Application
NA-Semax amidate has no injectable dose and no reconstitution — it is an intranasal product, so “dosing” means solution strength and how many drops, how often. What follows is the usual usage, framed honestly against the fact that the controlled data are for base Semax, not the amidate[1][3].
Standard / Gradual Approach
In practice, NA-Semax amidate is supplied as a 0.1% or 1% intranasal solution and used at a few drops per nostril, once or twice daily. Because the end-capping makes it longer-acting and stronger by weight than plain Semax, users take less of it for a comparable effect[1]. Exact drop counts vary by product concentration, so the solution strength matters more than a fixed “number of sprays.”
For context on how the parent compound is dosed clinically: Russian ischemic-stroke studies used base Semax in course-based intranasal regimens — for example about 6000 mcg/day for 10 days, repeated after a ~20-day interval[3]. That is a high-dose clinical protocol for a registered drug in acute stroke, not a nootropic maintenance dose, and it is for Semax, not the amidate.
The honest limit is that there is no validated amidate-specific dose-response. The percentages and drop counts are nootropic-market convention, and the potency claim is a pharmacological rationale (slower breakdown), not a clinically established equivalence. Conservative use of a known-concentration product is the sensible default.
Storage Instructions
Keep NA-Semax amidate solutions cool, sealed and out of light; peptides and their preservative systems degrade with heat and air, and a nasal solution can spoil if mishandled. Refrigeration is often recommended for peptide nasal sprays.
Use a product with a clearly stated concentration and a proper preservative, and discard anything that changes colour or smell. A correctly labelled, well-stored solution is what makes intranasal dosing predictable; an unlabelled or degraded one does not.
Important Notes
These are the points most often lost when NA-Semax amidate is marketed as a stronger “upgrade” to Semax.
- ▪It is a stabilized Semax, and the data are Semax’s: the neuroprotection, BDNF and antidepressant findings were generated with base Semax[1][2][4]. NA-Semax amidate’s own controlled human data are minimal; it inherits the evidence, not a separate proof.
- ▪“More potent” is a reason to use less: the end-capping slows breakdown, so the amidate is stronger by weight[1]. That narrows the margin for over-dosing — conservative amounts of a known-concentration solution are the sensible approach.
- ▪Registered in Russia, not FDA-approved: Semax is a registered intranasal drug in Russia; the amidate is a research/nootropic product. Neither is FDA-approved, and much of the clinical literature is Russian-language[3].
- ▪Intranasal, not injectable: Semax and its analogs are delivered into the nose; there is no basis for injecting NA-Semax amidate, and it should not be treated as an injectable peptide.
- ▪Know your concentration: because dosing is by drops of a percentage solution, the labelled strength is the whole safety margin — an unlabelled or wrongly concentrated product makes sane dosing impossible.
How This Works
Semax is a noncorticotropic analog of the ACTH(4-10) fragment — ACTH(4-7) extended with a C-terminal Pro-Gly-Pro that greatly increases its stability — so it carries ACTH’s neurotropic effects without stimulating cortisol release[1]. Its proposed mechanism centres on neurotrophins: Semax rapidly up-regulates BDNF and NGF and their receptors in the brain, and in cerebral-ischemia models it shifts protein expression toward neuroprotection (activating CREB, suppressing MMP-9 and pro-death signalling)[1][4].
Behaviourally and clinically, this translates into pro-cognitive, neuroprotective and antidepressant-like effects. In a chronic-stress rat model, Semax attenuated anhedonia and restored hippocampal BDNF[2], and in Russian clinical use for ischemic stroke it raised plasma BDNF and was associated with faster functional recovery[3]. The N-acetyl amidate modification does not change this pharmacology — it simply protects the peptide’s ends from exopeptidases, extending its duration and potency.
The honest limit is that the mechanistic and clinical data describe Semax, largely in animal models and Russian clinical settings, and the amidate is assumed to share them by virtue of being the same sequence, only more stable. That is a reasonable pharmacological inference — and it is not the same as a controlled demonstration that NA-Semax amidate specifically produces these effects in people[3].
Lifestyle Factors
For cognition and mood, the interventions with the strongest evidence are behavioural: sleep, aerobic exercise, managing stress and treating depression or anxiety properly, plus cognitive and social engagement. These raise BDNF and support the brain more reliably than any nootropic peptide.
The honest “daily habits” note is a redirection: proven brain- and mood-health basics carry evidence that a Russia-registered peptide analog does not, and they avoid the unknowns of self-dosing an unapproved intranasal compound.
Potential Benefits & Side Effects
Evidence tier: variant of Semax; the meaningful data are base-Semax data (animal and Russian clinical), not amidate-specific. The “effects” below are Semax findings the amidate is assumed to share; the “considerations” are the honest counterweight.
Reported Effects
- ▪Neuroprotection — Semax data: in cerebral ischemia-reperfusion models, Semax shifted brain protein expression toward neuroprotection and recovery (CREB up, MMP-9 and pro-death signalling down)[1].
- ▪Neurotrophin support — mechanistic: Semax up-regulates BDNF and NGF and their receptors in the brain, the proposed basis for its cognitive and protective effects[4].
- ▪Antidepressant-like and pro-recovery — preclinical/clinical: Semax attenuated stress-induced anhedonia and restored hippocampal BDNF in rats[2], and in Russian stroke practice raised plasma BDNF and sped functional recovery[3].
- ▪What is not established: that NA-Semax amidate specifically reproduces these effects in humans. Its own controlled trials are minimal, and Semax is not FDA-approved — the benefits are inherited from the Semax literature, not independently proven[3].
Common Side Effects
- ▪Generally reported as well tolerated — from Semax use: intranasal Semax is described as well tolerated, with mild local effects possible; the amidate is assumed similar, but its own safety data are minimal.
- ▪Nasal-route effects: as an intranasal product it can cause local nasal irritation; delivery technique and a clean, correctly concentrated solution matter.
- ▪Potency and concentration risk: because it is more potent and dosed by drops of a percentage solution, an unlabelled or over-concentrated product makes over-dosing easy — the labelled strength is the key safeguard.
- ▪Unapproved status: neither Semax nor the amidate is FDA-approved, and a grey-market solution has no guarantee of identity, concentration or purity.
How to Apply
Intranasal use is simple, and a clean nose and a known solution concentration matter more than technique. The steps below describe how a Semax-type nasal spray is typically used; they are educational, not medical instructions.
Preparation
- ▪Know the concentration: confirm whether your product is 0.1% or 1% — this sets how many drops make a dose, and it is the main safety margin.
- ▪Clear the nose: gently blow your nose so the solution can contact the nasal mucosa rather than sitting on mucus.
- ▪Start low: begin with the fewest drops of the lower-concentration option to gauge tolerance, especially since the amidate is more potent than plain Semax.
Using the Spray
- ▪Deliver into each nostril: place the drops or spray a few drops per nostril, tilting the head slightly and breathing gently so it stays in the nasal cavity rather than running to the throat.
- ▪Keep the total low: because it is potent, use less than you would of ordinary Semax; a couple of drops per nostril once or twice daily is the usual pattern.
- ▪Do not over-repeat: avoid frequent redosing chasing an effect — there is no validated amidate dose-response to justify escalation.
After Use
- ▪Re-cap and store cool: reseal the bottle and keep it cool and out of light (often refrigerated) to protect the peptide and preservative.
- ▪Watch for local reactions: mild nasal irritation is possible; persistent irritation is a reason to stop and reassess.
- ▪Keep expectations honest: effects are inferred from Semax; treat NA-Semax amidate as a more stable delivery of the same, unapproved pharmacology, not a proven cognitive drug.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides for N-Acetyl Semax Amidate (Intranasal (0.1% / 1%)).
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
References
- 1
International Journal of Molecular Sciences (2021) — Brain protein expression confirms the protective effect of Semax in a rat model of cerebral ischemia-reperfusionSudarkina et al. (PMID 34201112). Defines Semax as Met-Glu-His-Phe-Pro-Gly-Pro (ACTH(4-7)PGP) and shows, in the rat tMCAO stroke model, that it upregulates active CREB and downregulates MMP-9 and pro-death JNK/c-Fos signalling — a neuroprotective protein-expression profile. Base-Semax mechanism, not the amidate. DOI: 10.3390/ijms22126179.
- 2
European Journal of Pharmacology (2024) — Antidepressant-like and antistress effects of the ACTH(4-10) analog Semax in chronic unpredictable stressInozemtseva et al. (PMID 39442746). In a rat chronic-stress model, systemic Semax attenuated anhedonia and adrenal hypertrophy and reversed the stress-induced fall in hippocampal BDNF; describes Semax as a noncorticotropic ACTH(4-7)-Pro-Gly-Pro analog. Base-Semax data. DOI: 10.1016/j.ejphar.2024.177068.
- 3
Zh Nevrol Psikhiatr im S.S. Korsakova (2018) — Efficacy of Semax in patients at different stages of ischemic strokeGusev et al. (PMID 29798983). A clinical study (110 patients) of the registered intranasal Semax regimen (two 10-day courses of 6000 mcg/day with a 20-day interval): Semax raised plasma BDNF and was associated with faster functional recovery and better Barthel-index outcomes. Russian clinical use of base Semax. DOI: 10.17116/jnevro20181183261-68.
- 4
Molecular Biology (Mosk) (2011) — Effect of Semax and its C-end peptide PGP on neurotrophins and receptors in rat brain during ischemiaStavchansky et al. (PMID 22295573). Semax and its Pro-Gly-Pro fragment modulated the expression of neurotrophins (NGF, BDNF, NT-3) and their Trk/p75 receptors in the frontal cortex and hippocampus of ischemic rats, with a maximal effect in the hippocampus — the neurotrophin mechanism of base Semax.
How to apply N-Acetyl Semax Amidate
- 1Blend N-Acetyl Semax Amidate into a clean, water-based serum or cream base at the intended percentage (commonly 3 to 10 percent).
- 2Patch-test on a small area of skin first to check tolerability.
- 3Apply a thin layer to clean, dry skin as documented in cosmetic research (often once or twice daily).
- 4Store the raw powder and the finished serum sealed, cool and away from light; refrigerate water-based serums.
N-Acetyl Semax Amidate — frequently asked questions
How is N-Acetyl Semax Amidate used?
N-Acetyl Semax Amidate is a topical cosmetic peptide applied to the skin as part of a serum or cream — not injected or taken by mouth. It is blended into a water-based base at a chosen percentage and applied to clean skin.
What concentration of N-Acetyl Semax Amidate is typical?
Cosmetic formulations commonly use roughly 3 to 10 percent. Higher is not necessarily better and can affect texture, stability and skin tolerability. The strength shown on this page is a formulation reference, not a dose to inject.
Do I need bacteriostatic water or syringes for N-Acetyl Semax Amidate?
No. As a topical peptide, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — it is dissolved into a serum or cream base and applied to the skin.
How should I store N-Acetyl Semax Amidate?
Keep the raw powder sealed, cool, dry and away from light. A finished water-based peptide serum is best refrigerated and used within a few weeks, since peptides in solution degrade over time.
Is research-grade N-Acetyl Semax Amidate an approved drug?
No. N-Acetyl Semax Amidate is a cosmetic-grade ingredient for topical formulation and research, not an approved medicine; the evidence supports only modest topical, cosmetic effects. Everything here is research and educational information, not medical advice.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.